- Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: A systematic review and meta-analysis
- Oral contraception in adolescents with type 1 diabetes and its association with cardiovascular risk factors. A multicenter DPV study on 24 011 patients from Germany, Austria or Luxembourg
- Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults
- Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study
- Comparative effectiveness of tocilizumab vs TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: Analyses from the pan-European TOCERRA register collaboration
- Health status in patients with COPD treated with roflumilast: Two large noninterventional real-life studies: DINO and DACOTA
- Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis
- Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: An administrative claims database analysis
- Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
- Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme
- Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysis
- Persistence of and switches from teriparatide treatment among women and men with osteoporosis in the real world: A claims database analysis
- Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis
- Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: A population-based retrospective cohort study
- Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: A pilot randomized study
Feed Sources
